Celiac Disease
249
32
38
143
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
19 trials with published results (8%)
Research Maturity
143 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.0%
15 terminated out of 249 trials
90.5%
+4.0% vs benchmark
3%
8 trials in Phase 3/4
13%
19 of 143 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 143 completed trials
Clinical Trials (249)
Study of DONQ52 in Active Celiac Disease
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
Small Bowel Ultrasound and Antibody Levels in Celiac Disease Activity
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
Development of New Diagnostic Tools in Capsule Endoscopy
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Tissue Destruction and Healing in Celiac Disease
Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients
AI System for Detection and Characterization of Chronic Enteropathies
A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
VTP-1000 in Adults With Celiac Disease
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease